...
首页> 外文期刊>Combinatorial Chemistry & High Throughput Screening >Automated Planar Electrode Electrophysiology in Drug Discovery: Examples of the Use of QPatch in Basic Characterization and High Content Screening on Nav, KCa2.3, and Kv11.1 Channels
【24h】

Automated Planar Electrode Electrophysiology in Drug Discovery: Examples of the Use of QPatch in Basic Characterization and High Content Screening on Nav, KCa2.3, and Kv11.1 Channels

机译:药物发现中的自动平面电极电生理学:在Nav,KCa2.3和Kv11.1通道的基本表征和高内涵筛选中使用QPatch的示例

获取原文
获取原文并翻译 | 示例
           

摘要

Planar chip technology has strongly facilitated the progress towards fully automated electrophysiological systems that, in contrast to the traditional patch clamp technology, have the capability of parallel compound testing. The throughput has been increased from testing below 10 compounds per day to a realized capacity approaching high throughput levels. Many pharmaceutical companies have implemented automated planar chip electrophysiology in their drug discovery process, particularly at the levels of lead optimization, secondary screening and safety testing, whereas primary screening is generally not performed. In this review, we briefly discuss the technology and give examples from selected NeuroSearch ion channel programs, where one of the systems, the QPatch, has been evaluated for use in lead optimization and primary screening campaigns, where high information content was a requirement.
机译:平面芯片技术极大地推动了向全自动电生理系统的发展,与传统的膜片钳技术相比,该系统具有并行化合物测试的能力。吞吐量已从每天测试少于10种化合物增加到接近高吞吐量水平的已实现容量。许多制药公司已经在其药物发现过程中实现了自动化的平面芯片电生理学,特别是在铅优化,二级筛选和安全性测试方面,而通常不进行一级筛选。在这篇综述中,我们简要讨论了该技术,并从选定的NeuroSearch离子通道程序中提供了示例,其中已评估了其中一个系统QPatch用于铅优化和主要筛选活动,而这些活动要求高信息量。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号